Discovery Health Initiates Contempt Proceedings Over RAF Payment Dispute

In a defining moment for South African healthcare funding, Discovery Health has made significant legal strides by instituting contempt of court proceedings against the Road Accident Fund (RAF) and its CEO, Collins Letsoalo. This legal confrontation has been in the making for over a year, stemming from RAF's August 2022 directive halting the processing of claims filed by medical schemes.

The catalyst for this legal action can be traced back to an urgent high court application filed by Discovery Health in October 2022. The court ruled in favor of the health care giant, declaring the RAF's directive unlawful and demanding it be rescinded. However, despite this ruling, the RAF attempted to escalate the matter to the Constitutional Court, which ultimately declined to hear the case.

Now, Discovery Health is pushing for the Pretoria high court to acknowledge that the RAF and Letsoalo are in contempt, as they continue to refuse compensation claims from medical schemes despite the earlier legal directive—a move that purportedly goes against the norms established by the Prescribed Minimum Benefits within the Medical Schemes Act.

The issue at hand is not just about bureaucratic defiance; it has substantial financial implications too. Discovery Health has projected an annual loss of roughly R500 million due to the RAF's persistent rejection of its claims—funds that would otherwise be instrumental in covering medical costs for traffic accident victims.

Responding to the accusations, the RAF, through its chief governance officer, Mampe Kumalo, maintains that their new internal directives are structurally different from the one previously overturned and thus cannot be classified as contempt of court. The RAF centres its defense on the precarious nature of its financial status, describing the fund as not only "financially ailing" but "inadequately funded," a situation exacerbated by exploitation from fraudulent activities.

The RAF further emphasizes its responsibility under the Public Finance Management Act to safeguard its resources and operate within its legal obligations—paying out only what is deemed mandatory.

Discovery Health's move to take legal action represents a broader dispute concerning the obligations of the RAF to victims of road accidents who are also members of private medical schemes. By challenging the RAF's directives and their execution, Discovery Health is bringing the conversation to the forefront: Should the RAF cover private healthcare costs for "privileged citizens"?

With almost 100,000 claims filed annually, and the prevalence of fraudulent and exaggerated submissions, the RAF's challenge is to navigate through these obstacles with its limited resources, as elucidated by Letsoalo, who underscores the precision required in managing these funds.

As the impasse continues to unfold, the question remains: Will the RAF adhere to the high court's previous ruling, or will the procedural battle continue to delay the disbursements to medical schemes? All eyes are now set on the anticipated 2024 court hearing, which is expected to provide clarity and resolution to this impasse.